Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study.
Saved in:
| Title: | Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study. |
|---|---|
| Authors: | Murphy SL; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Balzer NR; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany., Ranheim T; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway., Sagen EL; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Huse C; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States., Bjerkeli V; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Michelsen AE; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Finbråten AK; Department of Internal Medicine, Lovisenberg Diakonal Hospital, Oslo, Norway., Heggelund L; Department of Internal Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway., Dyrhol-Riise AM; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital Ullevål, Oslo, Norway., Tveita A; Department of Internal Medicine, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.; Division of Laboratory Medicine, Department of Immunology, Oslo University Hospital, Oslo, Norway., Holten AR; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Acute Medicine, Oslo University Hospital, Oslo, Norway., Trøseid M; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway., Ueland T; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway., Ulas T; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany., Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway., Barratt-Due A; Division of Laboratory Medicine, Department of Immunology, Oslo University Hospital, Oslo, Norway.; Department of Anesthesia and Intensive Care Medicine, Oslo University Hospital, Oslo, Norway., Halvorsen B; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States., Dahl TB; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Jun 18; Vol. 15, pp. 1379570. Date of Electronic Publication: 2024 Jun 18 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38957465 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Murphy+SL%22">Murphy SL</searchLink>; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Balzer+NR%22">Balzer NR</searchLink>; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Ranheim+T%22">Ranheim T</searchLink>; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Sagen+EL%22">Sagen EL</searchLink>; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Huse+C%22">Huse C</searchLink>; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Bjerkeli+V%22">Bjerkeli V</searchLink>; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Michelsen+AE%22">Michelsen AE</searchLink>; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Finbråten+AK%22">Finbråten AK</searchLink>; Department of Internal Medicine, Lovisenberg Diakonal Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Heggelund+L%22">Heggelund L</searchLink>; Department of Internal Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Dyrhol-Riise+AM%22">Dyrhol-Riise AM</searchLink>; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital Ullevål, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Tveita+A%22">Tveita A</searchLink>; Department of Internal Medicine, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.; Division of Laboratory Medicine, Department of Immunology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Holten+AR%22">Holten AR</searchLink>; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Trøseid+M%22">Trøseid M</searchLink>; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Ueland+T%22">Ueland T</searchLink>; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Ulas+T%22">Ulas T</searchLink>; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Aukrust+P%22">Aukrust P</searchLink>; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Barratt-Due+A%22">Barratt-Due A</searchLink>; Division of Laboratory Medicine, Department of Immunology, Oslo University Hospital, Oslo, Norway.; Department of Anesthesia and Intensive Care Medicine, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Halvorsen+B%22">Halvorsen B</searchLink>; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Dahl+TB%22">Dahl TB</searchLink>; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Jun 18; Vol. 15, pp. 1379570. <i>Date of Electronic Publication: </i>2024 Jun 18 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38957465 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2024.1379570 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1379570 Titles: – TitleFull: Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Murphy SL – PersonEntity: Name: NameFull: Balzer NR – PersonEntity: Name: NameFull: Ranheim T – PersonEntity: Name: NameFull: Sagen EL – PersonEntity: Name: NameFull: Huse C – PersonEntity: Name: NameFull: Bjerkeli V – PersonEntity: Name: NameFull: Michelsen AE – PersonEntity: Name: NameFull: Finbråten AK – PersonEntity: Name: NameFull: Heggelund L – PersonEntity: Name: NameFull: Dyrhol-Riise AM – PersonEntity: Name: NameFull: Tveita A – PersonEntity: Name: NameFull: Holten AR – PersonEntity: Name: NameFull: Trøseid M – PersonEntity: Name: NameFull: Ueland T – PersonEntity: Name: NameFull: Ulas T – PersonEntity: Name: NameFull: Aukrust P – PersonEntity: Name: NameFull: Barratt-Due A – PersonEntity: Name: NameFull: Halvorsen B – PersonEntity: Name: NameFull: Dahl TB IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 06 Text: 2024 Jun 18 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |